RDNTNasdaqServices-Medical LaboratoriesFiscal year ends December 31

RadNet, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026

$69.27+0.47 (+0.68%)

Close on Oct 19, 2026

Market cap: $5.45B
P/E (TTM): –
Dividend yield: –

Dividends

RadNet has not reported a dividend

No dividend per share appears in RadNet's annual filings since fiscal 2010.

Where these numbers come from

Parsed from the XBRL in RadNet's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-2 reverse split on Nov 28, 2006
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is RDNT.

Revenue growth18.9% · median 13.6%

Operating margin3.1% · median 1.7%

Net margin-0.9% · median 1.0%

Company	Revenue	Growth
DGX	$11.56B	+9.9%
NTRA	$2.71B	+37.8%
RDNT	$2.27B	+18.9%
VCYT	$561.90M	+17.3%
FLGT	$323.93M	+6.8%
LMRI	–	–

Company

Next earnings (est.): Nov 9, 2026, before open
Exchange: Nasdaq
Industry: Services-Medical Laboratories
Fiscal year ends: December 31
Employees: 76
Held by institutions: 100.0%
Auditor: Ernst & Young LLP
SEC CIK: 790526

Advertisement
300 × 250